August J. Troendle - 19 Aug 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Reporting relationship: President & CEO, Director, 10%+ Owner
Issuer ticker: MEDP
Reported as of: 19 Aug 2026
Net transaction value: -$26,281,390
SEC form: 4
Accepted by SEC: 21 Aug 2026, 16:13:56 UTC
Prior SEC filing: 14 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/Stephen P. Ewald, Attorney-in-Fact for August J. Troendle

Key filing fact

August J. Troendle filed Form 4 for Medpace Holdings, Inc. (MEDP) on 21 Aug 2026.

Key facts

This page summarizes August J. Troendle's Form 4 filing for Medpace Holdings, Inc. (MEDP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 21 Aug 2026, 16:13.

Change

Previous filing in this sequence was filed on 14 Aug 2026.
Current net transaction value: -$26,281,390.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622058 Primary reporting owner

Troendle August J.

Relationship: President & CEO, Director, 10%+ Owner
Address: C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
Signature: /s/Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Signature date: 21 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MEDP transaction

Common Stock

Sale

Transaction value: $9,466,390
Shares: -15,609
Change %: -2.6%
Price: $606.47
Shares after: 588,369
Date: 19 Aug 2026
Ownership: Direct
Footnotes: F1, F2

MEDP transaction

Common Stock

Sale

Transaction value: $16,814,999
Shares: -27,174
Change %: -4.6%
Price: $618.79
Shares after: 561,195
Date: 20 Aug 2026
Ownership: Direct
Footnotes: F1, F3

MEDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,733,019
Date: 19 Aug 2026
Ownership: By Medpace Investors, LLC
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

Footnote F2

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $601.29 to $611.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Footnote F3

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $606.20 to $626.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Footnote F4

The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.